mPATH Health Raises $3 Million Funding

mPATH Health, the digital health company with a mission to make cancer screening as accessible as a morning cup of coffee, has just bagged a fresh $3 million in funding.

This impressive financial boost will turbocharge the company's work in cancer prevention and help close the gaps in health equity.

The $3 million isn’t just any ordinary pot of cash—$2 million came straight from the National Cancer Institute (NCI) through a Small Business Technology Grant, with another $1 million in equity investment from Oncology Ventures, a firm that's laser-focused on cancer care.

So, what’s all the buzz about?

mPATH’s cutting-edge cancer screening program has already shown it can double the number of screenings across various populations—no matter someone’s race, income, or even their literacy level.

Pretty amazing, right? Thanks to the NCI’s support, mPATH will be able to continue its rigorous clinical testing, develop new health modules, and expand the reach of its program.

But that’s not all. The $1 million from Oncology Ventures?

It’s a shot in the arm that will help mPATH move even faster—because when it comes to cancer prevention, speed is everything. The quicker we get people screened, the more lives can be saved.

Plus, more preventive health modules are on the horizon, making it easier for patients to stay ahead of potential health risks.

And it’s not just the funding that has everyone excited. The company’s tech-savvy approach—mixing behavioral science with the latest in automation—aims to put the power of health screenings right into the hands of patients.

We’re talking about personalized outreach that helps people take action on their health without all the usual barriers. Whether you’re juggling a busy schedule or simply unsure where to start, mPATH wants to make sure you’ve got everything you need to prioritize your health.

With this latest round of funding, mPATH is one step closer to changing the game in cancer screening.

By making early detection more accessible and affordable, the company is working toward a future where everyone gets a fair shot at beating cancer.

Let’s just say, it’s an exciting time to keep an eye on mPATH Health.